Posted on Leave a comment

Prostate Cancer Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Prostate Cancer Pipeline Insight 2025” report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in Prostate Cancer pipeline landscape. It covers the Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Prostate Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. […]

Posted on Leave a comment

Presbyopia Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Santen Pharma, Glaukos Corp., Ocuphire Pharma, Visus Therapeutics, LENZ

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Presbyopia pipeline constitutes 12+ key companies continuously working towards developing 12+ Presbyopia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   “Presbyopia Pipeline Insight, 2025“ report by DelveInsight outlines comprehensive insights into the present clinical development […]

Posted on Leave a comment

Small lymphocytic lymphoma Pipeline Appears Robust With 80+ Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Small Lymphocytic Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Small Lymphocytic Lymphoma pipeline landscape. It covers the Small Lymphocytic Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Small Lymphocytic Lymphoma therapeutics assessment by product type, stage, route of administration, […]

Posted on Leave a comment

Té Sana Unveils Wellness Products to Manage Anxiety and Menopause

Dr. Lisa Cortez pairs wellness products with a meditation center for holistic treatment HOUSTON – May 7, 2025 – Té Sana has developed a holistic approach to wellness with their Pure Wellness Collection. This collection boasts non-toxic skincare products, therapeutic teas, and mindfully crafted candles for women navigating symptoms of anxiety, perimenopause, and menopause. Té […]

Posted on Leave a comment

Glioma Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive […]

Posted on Leave a comment

PD-1 NSCLC Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Genor Biopharma, Shandong Boan Biotechnology, Pfizer, AstraZeneca, Lepu Biopharma, GlaxoSmithKline

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies continuously working towards developing 30+ PD-1 Non-Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   The PD-1 Non-Small Cell Lung Cancer Pipeline […]

Posted on Leave a comment

Ibogaine Clinic Leadership Finalizes Conference Strategy, Emphasizes Personalized Treatment and Future Research

CORAL SPRINGS, FL – May 5, 2025 – Key leadership from Ibogaine Clinic, including Gavriel Dardashti, Cole Barressi, and Misty Huckabey, convened recently to strategically plan their participation in an upcoming industry conference. The meeting focused on optimizing the clinic’s presence, showcasing their unique treatment methodologies, and outlining plans for future data collection and research. […]

Posted on Leave a comment

eClinical Solutions Market worth $22.1 billion by 2029 driven by Rising Chronic Illness Rates

Asia-Pacific market was the fastest growing market, however, the growth was backed by the emerging pharmaceutical companies, clinical trial activity and increased healthcare expenditure in countries such as China and India. The global eclinical solutions market, valued at US$10.3B in 2023, is forecasted to grow at a 13.7% CAGR, reaching US$11.62B by 2024 and US$22.09B […]

Posted on Leave a comment

Cutaneous Squamous cell Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline landscape. It covers the Cutaneous Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cutaneous Squamous Cell Carcinoma therapeutics assessment by product type, […]

Posted on Leave a comment

Rotator Cuff Injuries Market Poised for Significant Growth by 2032, Driven by Innovative Biologics and Regenerative Therapies | DelveInsight

Rotator Cuff Injuries Market Report The rotator cuff injuries treatment market is expected to witness substantial growth, primarily fueled by an increasing prevalence, an aging population, advancements in minimally invasive surgical techniques, and the emergence of novel biologic therapies. Key rotator cuff repair companies, including Ortho Regenerative Technologies, Angiocrine Bioscience, Smith & Nephew, Arcuro Medical, […]